The trademark application COVIFENZ was filed by Medicago inc., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on September 14, 2020, and it was registered by office on December 22, 2020 without any oppositions.
The application was filed in French (English was selected as the second language).
Change of name and address of the trademark registration was recorded on January 8, 2024.